Radiation-associated Carotid Artery Disease in Patients With Nasopharyngeal Carcinoma

Sponsor
Fudan University (Other)
Overall Status
Unknown status
CT.gov ID
NCT03568032
Collaborator
(none)
248
1
12
20.7

Study Details

Study Description

Brief Summary

Radiation-associated carotid vasculopathy is a common late sequelae in patients with head and neck cancer, which correlates with the incidence of stroke. Currently, little is known about the incidence of radiation-associated carotid vasculopahty in the context of intensity-modulated radiation therapy (IMRT).

The aim of this study is to determine whether IMRT will increase the incidence of carotid vasculopathy in patients with nasopharyngeal carcinoma (NPC).

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Measurement of intima media thickness of carotid artery
  • Diagnostic Test: Detection and measurement of carotid plaques
  • Diagnostic Test: Carotid Color Flow Duplex Testing
  • Diagnostic Test: Montreal Cognitive Assessment
  • Other: Medical history of cardiovascular risk factors and cardiovascular diseases

Study Design

Study Type:
Observational
Anticipated Enrollment :
248 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
The Clinical Study of Radiation-associated Carotid Artery Disease in Patients With Nasopharyngeal Carcinoma Treated by IMRT
Anticipated Study Start Date :
Jul 1, 2018
Anticipated Primary Completion Date :
May 1, 2019
Anticipated Study Completion Date :
Jun 30, 2019

Arms and Interventions

Arm Intervention/Treatment
the post-radiation group

patients diagnosed as non-metastatic nasopharyngeal carcinoma who received definitive IMRT more than 3 years ago

Diagnostic Test: Measurement of intima media thickness of carotid artery
IMT measurements were performed using ultrasound machine in the pre-radiation and the post-radiation group. IMT was assessed at the common carotid artery (CCA) and the internal carotid artery (ICA) of both the left and right side.

Diagnostic Test: Detection and measurement of carotid plaques
Detection and measurement of plaques within internal carotid artery and common carotid artery by ultrasound

Diagnostic Test: Carotid Color Flow Duplex Testing
Velocity measurement of carotid artery to determine carotid stenosis

Diagnostic Test: Montreal Cognitive Assessment
Cognitive assessment

Other: Medical history of cardiovascular risk factors and cardiovascular diseases
Cardiovascular risk factors include smoking, alcohol consumption, hypertension, diabetes mellitus, hypercholesterolemia, obesity. Cardiovascular diseases include ischemic stroke, ischemic coronary heart disease, TIA, etc.

the pre-radiation group

untreated patients diagnosed as non-metastatic nasopharyngeal carcinoma

Diagnostic Test: Measurement of intima media thickness of carotid artery
IMT measurements were performed using ultrasound machine in the pre-radiation and the post-radiation group. IMT was assessed at the common carotid artery (CCA) and the internal carotid artery (ICA) of both the left and right side.

Diagnostic Test: Detection and measurement of carotid plaques
Detection and measurement of plaques within internal carotid artery and common carotid artery by ultrasound

Diagnostic Test: Carotid Color Flow Duplex Testing
Velocity measurement of carotid artery to determine carotid stenosis

Diagnostic Test: Montreal Cognitive Assessment
Cognitive assessment

Other: Medical history of cardiovascular risk factors and cardiovascular diseases
Cardiovascular risk factors include smoking, alcohol consumption, hypertension, diabetes mellitus, hypercholesterolemia, obesity. Cardiovascular diseases include ischemic stroke, ischemic coronary heart disease, TIA, etc.

Outcome Measures

Primary Outcome Measures

  1. intima media thickness of carotid artery [This is a cross-sectional study. So the time frame is within one week of a patient-visit to the clinics.]

    the intima media thickness of common carotid artery, internal carotid artery of the left or right side

Secondary Outcome Measures

  1. the incidence of carotid stenosis [This is a cross-sectional study. So the time frame is within one week of a patient-visit to the clinics.]

    Carotid stenosis is defined as the axial diameter of the carotid lumina decreases more than 50%.

  2. the number of carotid plaques [This is a cross-sectional study. So the time frame is within one week of a patient-visit to the clinics.]

    Carotid plaque is defined as a focal structure that encroaches into the arterial lumen of at least 0.5 mm or 50% of the surrounding IMT value or demonstrates a thickness >1.5 mm as measured from the media-adventitia interface to the intima- lumen interface.

  3. total number of Montreal Cognitive Score (range: 0-30) [This is a cross-sectional study. So the time frame is within one week of a patient-visit to the clinics.]

    the higher the number, the better the cognitive function

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • signed inform consent

  • age more than 18 years old

  • ECOG 0-2

  • pathologic diagnosed, non-metastatic NPC

  • either untreated or treated by definitive IMRT 3 years ago

  • did not receive radiation to the head and neck region prior to the diagnosis of NPC

  • if the patient received definitive IMRT 3 years ago because of NPC, he or she did not receive a second course of radiation due to local relapse

  • no prior surgery of head and neck

Exclusion Criteria:
  • prior history of cardiovascular disease before the diagnosis of NPC

  • prior radiation to head and neck before the diagnosis of NPC

  • prior surgery of head and neck

  • pregnant or lactating women

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fudan University Shanghai Cancer Center Shanghai Shanghai China 200032

Sponsors and Collaborators

  • Fudan University

Investigators

  • Principal Investigator: Xiayun He, MD, Fudan University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Xiayun He, MD, Principal Investigator, Clinical Professor, Fudan University
ClinicalTrials.gov Identifier:
NCT03568032
Other Study ID Numbers:
  • NPC-CAROTID-01
First Posted:
Jun 26, 2018
Last Update Posted:
Jun 26, 2018
Last Verified:
Jun 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Xiayun He, MD, Principal Investigator, Clinical Professor, Fudan University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 26, 2018